相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Superoxide: A major role in the mechanism of action of essential antimalarial drugs
Chinedu O. Egwu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Artemisinin derivatives inhibit adipogenic differentiation of 3T3-L1 preadipocytes through upregulation of CHOP
Guoying Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Recent treatment progress of triple negative breast cancer
Yang Chang-Qing et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2020)
Triple negative breast cancer: A thorough review of biomarkers
Jesse Lopes da Silva et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Realizing the Potential of Blueberry as Natural Inhibitor of Metastasis and Powerful Apoptosis Inducer: Tapping the Treasure Trove for Effective Regulation of Cell Signaling Pathways
Sundas Fayyaz et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)
Plasmodium falciparum Artemisinin Resistance: The Effect of Heme, Protein Damage, and Parasite Cell Stress Response
Melissa R. Rosenthal et al.
ACS INFECTIOUS DISEASES (2020)
Heme-Dependent ER Stress Apoptosis: A Mechanism for the Selective Toxicity of the Dihydroartemisinin, NSC735847, in Colorectal Cancer Cells
Ahmed E. M. Elhassanny et al.
FRONTIERS IN ONCOLOGY (2020)
Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53
Xinyu Zhou et al.
CANCERS (2020)
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Antonio Marra et al.
NPJ BREAST CANCER (2020)
Artesunate, as a HSP70 ATPase activity inhibitor, induces apoptosis in breast cancer cells
Masoud Pirali et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice
Yuchao Chen et al.
THERANOSTICS (2020)
Transferrin and transferrin receptors update
Hiroshi Kawabata
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Development of artemisinin resistance in malaria therapy
Janine Nass et al.
PHARMACOLOGICAL RESEARCH (2019)
The C/EBP Homologous Protein (CHOP) Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced Apoptosis and Microbial Infection
Hai Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Miseon Lee et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2019)
Mechanisms of the pH- and Oxygen-Dependent Oxidation Activities of Artesunate
Katsunori Tsuda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Artesunate shows potent anti-tumor activity in B-cell lymphoma
Thea Kristin Vatsveen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
Jasmine M. Manouchehri et al.
ANTICANCER RESEARCH (2018)
Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway
Yanmei Liu et al.
CANCER MEDICINE (2018)
Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells
Chao-Ming Hung et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Thomas Efferth
SEMINARS IN CANCER BIOLOGY (2017)
The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover
David J. Wilkinson et al.
SCIENTIFIC REPORTS (2017)
Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment
Kanchan Kumari et al.
BMC CANCER (2017)
Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression
Elena Strekalova et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives
Archana Bhaw-Luximon et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
Long He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells
Zhao-Tong Wang et al.
CELLULAR SIGNALLING (2016)
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
Maura N. Dickler et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate
Kefeng Liu et al.
SCIENTIFIC REPORTS (2016)
AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells
Shaopeng Chen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL
Rhiannon French et al.
MOLECULAR CANCER (2015)
Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage
Kamila A. Marzec et al.
ONCOTARGET (2015)
Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin
Yan Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
Ingrid A. M. van Roosmalen et al.
SPRINGERPLUS (2014)
Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
Xiaobing Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants
C. R. Reis et al.
CELL DEATH & DISEASE (2010)
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
Monzur Rahman et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis
Ikuhiko Nakase et al.
CANCER LETTERS (2009)
Superoxide is the major reactive oxygen species regulating autophagy
Y. Chen et al.
CELL DEATH AND DIFFERENTIATION (2009)
Binding of artemisinin to holotransferrin: Electrochemical and spectroscopic characterization
Huai-Hong Cai et al.
JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2008)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor
Almer M. van der Sloot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lyssavirus matrix protein induces a poptosis by a TRAIL-dependent mechanism involving caspase-8 activation
R Kassis et al.
JOURNAL OF VIROLOGY (2004)
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
R Takimoto et al.
ONCOGENE (2000)
分享论文
